Ignite Creation Date:
2024-05-06 @ 3:02 AM
Last Modification Date:
2024-10-26 @ 11:27 AM
Study NCT ID:
NCT02191930
Status:
COMPLETED
Last Update Posted:
2022-08-08
First Post:
2014-07-11
Brief Title:
Brentuximab Vedotin or B-CAP in the Treatment of Older Patients With Newly Diagnosed Classical Hodgkin Lymphoma
Sponsor:
University of Cologne
Organization:
University of Cologne
Organization Data
Organization:
University of Cologne
Class:
OTHER
Study ID:
B-CAP
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Cologne
Lead Sponsor Class:
OTHER
Responsible Party:
Prof Dr Peter Borchmann
Responsible Party Title:
Prof
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Cologne
Old Name:
None
Old Organization:
None